Target Group Inc (CBDY)
0.0054
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Target Group Profit Margin (Quarterly): -9.66% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.66% |
| September 30, 2023 | -34.10% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -754.4K% |
| September 30, 2017 | -239.2K% |
| June 30, 2017 | -401.5% |
| March 31, 2017 | -56.72K% |
| December 31, 2016 | -10.48K% |
| September 30, 2016 | -295.9K% |
| June 30, 2016 | -6.37K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-34.10%
Minimum
Sep 2023
-9.66%
Maximum
Dec 2023
-21.88%
Average
-21.88%
Median
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -3.90% |
| Gross Profit Margin (Quarterly) | 35.16% |
| Operating Margin (Quarterly) | 3.59% |
| Return on Net Operating Assets | -4.12% |